NPPB and myocardial infarction: Several features point to the EMMY cohort being at a lower risk of progressive adverse remodelling than that recruited in EMPRESS‐MI; in EMMY the ventricular volumes were almost half of those in EMPRESS‐MI, LVEF was substantially higher (49% vs. 36% in the placebo group) and baseline troponin T and NT‐proBNP were lower than in EMPRESS‐MI.